| Dr Dekui Zhang, MD | |
|
2400 17th St, Columbus, IN 47201-5351 | |
| (812) 373-3024 | |
| (812) 376-0678 |
| Full Name | Dr Dekui Zhang |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 40 Years |
| Location | 2400 17th St, Columbus, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043330012 | NPI | - | NPPES |
| 000000991121 | Other | ANTHEM PIN | |
| 200953940 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 01064890A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alamance Regional Medical Center | Burlington, NC | Hospital |
| Moses H. Cone Memorial Hospital, The | Greensboro, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Moses Cone Physician Services, Inc | 4284782210 | 306 |
News Archive
Human clinical trials involving investigational vaccines to prevent Hepatitis C are rare. In the fall of 2003 there was a first-ever study at Saint Louis University Center for Vaccine Development, and an earlier small study at Johns Hopkins School of Medicine.
A breakthrough study by research teams at Rosalind Franklin University of Medicine and Science and Oregon Health & Science University offers promise for therapeutic management of congenital diseases in utero using designer nucleotide sequences that can simply be injected into the fluid surrounding the developing fetus to potentially treat disabling-to-lethal genetic defects.
A study carried out by researchers at Massachusetts General Hospital (MGH) and the Perelman School of Medicine at the University of Pennsylvania finds that low wages and poor benefits leave many female health care workers living below the poverty line.
iCONECT, developers of the award winning, visually rich and intuitively simple XERA e-discovery software, announced today that it is establishing a partnership with Lockheed Martin's Information Systems & Global Solutions to address application decommissioning needs in the U.S. commercial healthcare industry, consolidate silos of legacy electronic medical records (EMR), and reduce the cost of preserving and accessing these records.
A synthetic cannabis-like drug in a pill was safe and effective in treating obstructive sleep apnea in the first large multi-site study of a drug for apnea funded by the National Institutes of Health. The study was conducted at Northwestern Medicine and the University of Illinois at Chicago.
› Verified 5 days ago
| Entity Name | Moses Cone Physician Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093953127 PECOS PAC ID: 4284782210 Enrollment ID: O20090501000202 |
News Archive
Human clinical trials involving investigational vaccines to prevent Hepatitis C are rare. In the fall of 2003 there was a first-ever study at Saint Louis University Center for Vaccine Development, and an earlier small study at Johns Hopkins School of Medicine.
A breakthrough study by research teams at Rosalind Franklin University of Medicine and Science and Oregon Health & Science University offers promise for therapeutic management of congenital diseases in utero using designer nucleotide sequences that can simply be injected into the fluid surrounding the developing fetus to potentially treat disabling-to-lethal genetic defects.
A study carried out by researchers at Massachusetts General Hospital (MGH) and the Perelman School of Medicine at the University of Pennsylvania finds that low wages and poor benefits leave many female health care workers living below the poverty line.
iCONECT, developers of the award winning, visually rich and intuitively simple XERA e-discovery software, announced today that it is establishing a partnership with Lockheed Martin's Information Systems & Global Solutions to address application decommissioning needs in the U.S. commercial healthcare industry, consolidate silos of legacy electronic medical records (EMR), and reduce the cost of preserving and accessing these records.
A synthetic cannabis-like drug in a pill was safe and effective in treating obstructive sleep apnea in the first large multi-site study of a drug for apnea funded by the National Institutes of Health. The study was conducted at Northwestern Medicine and the University of Illinois at Chicago.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dekui Zhang, MD 3875 West Presidential Way, Suite H, Edingburgh, IN 46124 Ph: (812) 348-4000 | Dr Dekui Zhang, MD 2400 17th St, Columbus, IN 47201-5351 Ph: (812) 373-3024 |
News Archive
Human clinical trials involving investigational vaccines to prevent Hepatitis C are rare. In the fall of 2003 there was a first-ever study at Saint Louis University Center for Vaccine Development, and an earlier small study at Johns Hopkins School of Medicine.
A breakthrough study by research teams at Rosalind Franklin University of Medicine and Science and Oregon Health & Science University offers promise for therapeutic management of congenital diseases in utero using designer nucleotide sequences that can simply be injected into the fluid surrounding the developing fetus to potentially treat disabling-to-lethal genetic defects.
A study carried out by researchers at Massachusetts General Hospital (MGH) and the Perelman School of Medicine at the University of Pennsylvania finds that low wages and poor benefits leave many female health care workers living below the poverty line.
iCONECT, developers of the award winning, visually rich and intuitively simple XERA e-discovery software, announced today that it is establishing a partnership with Lockheed Martin's Information Systems & Global Solutions to address application decommissioning needs in the U.S. commercial healthcare industry, consolidate silos of legacy electronic medical records (EMR), and reduce the cost of preserving and accessing these records.
A synthetic cannabis-like drug in a pill was safe and effective in treating obstructive sleep apnea in the first large multi-site study of a drug for apnea funded by the National Institutes of Health. The study was conducted at Northwestern Medicine and the University of Illinois at Chicago.
› Verified 5 days ago
Dr. Natasha Singh, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-373-3025 Fax: 812-348-7497 | |
Dr. Drew Hundley, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5974 Fax: 812-375-3203 | |
Dr. Robert Neil Elliott, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5974 Fax: 812-375-3203 | |
Dr. Nafia Ashique, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5974 Fax: 812-375-3203 |